| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |